Hi Frogdreaming,
As to your follow-up:
Share dilution with the Dutchess Agreement will provide DNAP with 35 million.
Could you please elaborate? my concern lies with the current market cap. As there does not appear to be any significant change in the status quo on the short term horizon, it seems to be a fairly large inconsistency to expect to extract $35 million via a dilutive process from a company valued at less than half that amount.
-I agree with you that there is an inconsistency as per the needed capital compared to extracting it from the current pps. Therefore, it is very likely that one, some, or all of three things would need to happen: either a r/s (vote on), an increase in shares(vote on), or an increase in the pps.
As to your second question:
So it is likely that any push for a r/s is for greater returns for share dilution. As of right now I probably will not be voting for a r/s.
Given that the Dutchess $35 Million Agreement will require sufficient shares to support it, and realizing that under the present share structure there are less than 500 Million available shares, most of them already committed to LaJolla, how do you envision the completion of the Dutchess Agreement without a R/S?
As a reference, IF all of the current 500 Million shares were available, it would still require a pps of .14 to complete the deal.
-Direct to the question, how do you envision the completion of the Dutchess Agreement without a R/S? I am hopeful that the price will continue to go up. However, if this does not happen I would rather vote for more shares without a r/s. Much depends on the pipeline products (stat, ov, & Ret HA). If these products can generate a greater revenue stream and if DNAP can control their costs to a degree earnings will improve and perhaps push the stock price up. To the point I feel it’s early to consider a r/s because it does not get you on an exchange and that is the main reason for a company at this stage to consider a r/s.
I hope that clarifies the points that I made.
Big Blue
